Bill > HB06355

This bill requires individual and group health insurance policies to provide coverage for biomarker testing. Biomarker testing is a diagnostic method that involves analyzing molecules in blood, tissue, or other body fluids to help detect, diagnose, or monitor diseases, particularly cancer. By mandating insurance coverage for this type of testing, the bill aims to improve patient access to potentially critical medical diagnostic procedures that can help identify disease risks or guide more personalized treatment plans. The proposed legislation would amend Chapter 700c of the general statutes to ensure that health insurance providers include biomarker testing as a covered service, which could help reduce out-of-pocket costs for patients and encourage earlier detection and more precise medical interventions.

Business and Industry

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=HB06355&which_year=2025